Visfatin mediates doxorubicin resistance in human non-small-cell lung cancer via Akt-mediated up-regulation of ABCC1.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Huaxia Yang Naixin Liang |
| Publication date | August 1, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |